Envestnet Portfolio Solutions Inc. Sells 1,837 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Envestnet Portfolio Solutions Inc. reduced its stake in HCA Healthcare by 12.9%, selling 1,837 shares and bringing total holdings to 12,443 shares worth $4.77 million.
• Multiple institutional investors have recently acquired stakes in HCA, with 62.73% of the company's stock owned by hedge funds and other institutions.
• HCA Healthcare reported quarterly earnings of $6.84 per share, exceeding analysts' expectations, with a total revenue of $18.61 billion, reflecting a 6.4% increase from the previous year.

Envestnet Portfolio Solutions Inc. trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,443 shares of the company's stock after selling 1,837 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in HCA Healthcare were worth $4,767,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in HCA. Cheviot Value Management LLC purchased a new position in HCA Healthcare during the first quarter valued at approximately $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare during the first quarter valued at $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare during the first quarter valued at $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare during the second quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at $27,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Truist Financial set a $460.00 target price on shares of HCA Healthcare in a research report on Tuesday. UBS Group raised their target price on shares of HCA Healthcare from $438.00 to $495.00 and gave the company a "buy" rating in a research report on Tuesday. Royal Bank Of Canada cut their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $431.07.

HCA Healthcare Stock Up 0.5%

HCA stock opened at $420.38 on Thursday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $439.01. The stock has a market capitalization of $98.37 billion, a PE ratio of 17.67, a price-to-earnings-growth ratio of 1.32 and a beta of 1.40. The firm has a 50 day moving average of $408.25 and a 200 day moving average of $377.15.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the firm posted $5.50 EPS. HCA Healthcare's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.